glp 1 cancer Can GLP-1 Medications Reduce Breast Risk? The effect of GLP-1R agonists

In documents ahead of this weeks meeting, the agency said there is little evidence supporting the safety or effectiveness of the seven compounds under review, citing inadequate human clinical trials and concerns about their quality, stability and consistency

Ferroptosis promotes t-cell activation-induced neurodegeneration in multiple sclerosis

When GLP-1 drugs are started or stopped without proper clinical assessment, follow-up and lifestyle support, patients may experience rebound weight gain and other health complications

N-ACetylcysteine to Reduce Infection and Mortality for Alcoholic Hepatitis (NACAH)

Spitsin S, Hooper DC, Mikheeva T, Koprowski H